Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 121,718	$ 81,787
Research and development incentive receivable	1,152	747
Prepaid expenses and other current assets	5,807	5,344
Total current assets	128,677	87,878
Property and equipment, net	1,104	1,514
Goodwill	17,351	17,351
Right-of-use assets	7,229	8,710
Other assets	1,225	1,723
Assets, Total	155,586	117,176
Current liabilities:
Accounts payable	7,777	4,283
Accrued expenses	12,034	7,870
Current portion of lease liability	1,198	1,075
Long-term Debt, Current Maturities	1,315	795
Liabilities, Current, Total	22,324	14,023
Long-term debt, including accretion, net of discount	32,304	33,139
Lease liabilities	3,603	4,776
Warrant liability (Note 4)	23,131	0
Other liabilities	173	826
Total liabilities	81,535	52,764
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common Stock	122	28
Additional paid-in capital	450,786	347,374
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(376,738)	(282,871)
Total stockholders’ equity	74,051	64,412
Total liabilities and stockholders’ equity	$ 155,586	$ 117,176